NMRANeumora Therapeutics Inc. Common Stock
1.630USD-0.61%Mkt Cap: 306.27M $P/E: —3d ago
Neumora Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutic treatments for brain diseases, neuropsychiatric disorders, and neurodegenerative diseases in the United States. Th…
Industry Peers
Biotechnology$138.82BUSDP/E 31.9
$85.87BUSDP/E 20.5
$61.34BUSDP/E 39.8
$65.05BUSDP/E 39.6
$57.94BUSD
$45.95BUSDP/E 19.6
$44.89BUSD
$42.36BUSDP/E 67.2
$35.43BUSDP/E 32.6
$31.61BUSDP/E 41.2
$29.28BUSD
$27.47BUSD
$26.22BUSD
$25.91BUSDP/E 16.2
$20.86BUSDP/E 26.3
$19.26BUSDP/E 26.6
$16.61BUSDP/E 19.6
$16.51BUSDP/E 17.4
$15.93BUSD
$13.40BUSDP/E 17.0
Key Statistics
Company
Market Cap306.27M $
Enterprise Value221.08M $
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-236.93M $
Revenue/Share—
Last Price1.630 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees63
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-2.26
PEG—
EV/EBITDA-1.07
EV/Revenue—
P/S—
P/B6.37
EPS (TTM)-1.14
EPS (Forward)-0.67
52W Range
0.830228% of range3.650
52W High3.650 USD
52W Low0.8302 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-228.10%
ROA-124.02%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-206.44M $
CapEx (TTM)—
FCF Margin—
FCF Yield-32.46%
Net Debt-63.58M $
Net Debt/EBITDA0.31
Balance Sheet
Debt/Equity0.53
Current Ratio4.50
Quick Ratio4.21
Book Value/Sh0.2380 USD
Cash/Share0.6220 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.8 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)6.143 USD
Upside (mean)+276.9%
Target Range3.000 USD – 14.00 USD
$3.000+276.9% to mean$14.00
# Analysts7
Ownership
Shares Out.187.90M
Float116.38M
Insiders23.25%
Institutions60.11%
Short Interest
Short Ratio8.7d
Short % Float7.10%
Short % Out.4.11%
Shares Short7.62M
Short (prev mo.)6.68M
Technical
SMA 501.607 (+1.4%)
SMA 2002.134 (-23.6%)
Beta2.78
S&P 52W Chg18.16%
Avg Vol (30d)699.79K
Avg Vol (10d)812.64K
Technical Indicators
RSI (14)49.7
MACD-0.0023
MACD Signal-0.0011
MACD Hist.-0.0012
BB Upper1.746 USD
BB Middle1.629 USD
BB Lower1.511 USD
BB Width14.37%
ATR (14)0.1199 USD
Vol Ratio (20d)0.72x